Esperion Therapeutics
Stephen Pinkosky is an accomplished professional with extensive experience in research and development. Currently serving as Executive Director of R&D at Esperion since December 2008, Stephen has previously held scientific roles at Aastrom Biosciences and Pfizer from 2004 to 2008. Educationally, Stephen holds a Doctor of Philosophy (PhD) in Nutrition and Metabolism from McMaster University, a Master's degree in Cell/Cellular and Molecular Biology from the University of Michigan, and a Bachelor's degree in Microbiology and Immunology from Michigan State University.
This person is not in any teams
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.